| 发明名称 |
Use of a combination of agents that modulate b7 activity in inhibiting intestinal allograft rejection |
| 摘要 |
The invention provides a method of downmodulating the immune response to an intestinal allograft in a subject comprising administering to the subject an antibody that binds to B7-1 and an antibody that binds to B7-2. |
| 申请公布号 |
AU4361701(A) |
申请公布日期 |
2001.09.24 |
| 申请号 |
AU20010043617 |
申请日期 |
2001.03.13 |
| 申请人 |
GENETICS INSTITUTE INC. |
发明人 |
MARY COLLINS;KENNETH NEWELL |
| 分类号 |
A61K39/395;A61P37/06;C07K16/28 |
主分类号 |
A61K39/395 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
